Analysis: VeriSilicon's HD audio IP solution
January 30, 2008 -- dspdesignline.com
VeriSilicon has released a licenseable DSP core, the ZSP800, and an associated development platform, VZ.AudioHD, optimized for "HD" audio applications.

VeriSilicon's VZ.AudioHD platform builds on the company's earlier VZ.Audio platform. The VZ.AudioHD platform includes optimized software for many of the required compression algorithms. Verisilcon acquired the "ZSP" family of DSP cores from LSI Logic in 2006. The ZSP family includes a large number of DSP cores aimed at a wide variety of markets including portable audio players, DVD players, personal music players, VoIP hardware, and other wired and wireless communications devices.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Verisilicon, Inc. Hot IP
Related News
- VeriSilicon's complete Bluetooth Low Energy IP solution is fully compliant with LE Audio specification
- NXP HD Voice Processing Smartphone Software Now Available for Tensilica's HiFi Audio/Voice DSPs
- Tensilica's HiFi Audio DSP First IP Core to Support SRS' Advanced StudioSound HD Audio Suite for HDTVs
- CEVA-TeakLite-III DSP Core Powers HD Audio in Sunplus' New Blu-ray SoCs
- CEVA Introduces Industry's Most Compact and Power-Efficient Single-Core DSP Solution for HD Audio Applications
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design